Group 1 - Huakang Co., Ltd. plans to acquire 100% equity of Henan Yuxin Sugar Alcohol Co., Ltd. for a transaction price of 1.098 billion yuan [1] - Company A is the largest customer of Yuxin Sugar Alcohol in 2023 and the second largest customer in 2024 [1] - The specific name of Company A has not been disclosed by Huakang Co., Ltd. [2] Group 2 - Investigation reveals that Company A is Shandong Futian Pharmaceutical Co., Ltd., which is facing issues such as frozen accounts, asset enforcement, and restrictions on high consumption for its legal representative [2]

Core Points - Huakang Co., Ltd. announced the signing of a share transfer agreement with Mr. Fang Ming on August 7, 2025, to transfer 9,880,880 shares of Ningbo Traditional Chinese Medicine through the National Equities Exchange and Quotations (NEEQ) platform for a total price of RMB 24,899,817.60 [1] Summary by Category Company Actions - The company will no longer hold any shares in Ningbo Traditional Chinese Medicine after the completion of this transfer [1] Financial Details - The total transfer price for the shares is RMB 24,899,817.60 [1]

Group 1: Company Announcements - Tengjing Technology has terminated the issuance of shares and cash payment for asset acquisition due to changes in market conditions and difficulties in reaching an agreement with transaction parties [1] - Tongyuan Environment has won a joint bid for the comprehensive treatment project of municipal solid waste in Salting County, with a total bid amount of 154 million yuan, and the company's expected share is 123 million yuan [2] - Huakang Co. plans to transfer 9.8809 million shares of Ningbo Traditional Chinese Medicine for a total price of 24.8998 million yuan, after which it will no longer hold any shares in the company [3] Group 2: Sales and Financial Performance - Seres reported a 5.7% year-on-year increase in new energy vehicle sales in July, totaling 44,581 units, while cumulative sales for the year have decreased by 10.87% to 216,700 units [4] - Xiantan Co. achieved chicken product sales revenue of 511 million yuan in July, with sales volume of 59,600 tons, reflecting year-on-year changes of 18.19% and 24.92% respectively [7] - Lidong Group's subsidiaries have received project notifications from two major clients, with expected total sales of approximately 1.643 billion yuan over the project lifecycles [8] Group 3: Procurement and Investment - Geler Software plans to raise no more than 283 million yuan through a private placement to fund projects related to quantum-resistant password technology and data space platform development [6] - GCL-Poly Energy's subsidiary has signed a framework contract to purchase silicon materials from Zhongneng Silicon Industry, with a total procurement amount expected to be no more than 450 million yuan [8] - Lihexing intends to raise no more than 168 million yuan through a private placement for semiconductor equipment precision component development and working capital [10] Group 4: Shareholding Changes - Tongfu Microelectronics announced that the National Integrated Circuit Industry Investment Fund reduced its shareholding by 13.1424 million shares, decreasing its ownership from 7.77% to 6.91% [9]

Core Viewpoint - Huakang Co., Ltd. plans to transfer its 9,880,900 shares in Ningbo Traditional Chinese Medicine Pharmaceutical Co., Ltd. for a total consideration of 24.8998 million yuan, resulting in the company no longer holding any shares in Ningbo Traditional Chinese Medicine after the transfer [1]. Group 1 - The share transfer is part of the company's strategic development and operational adjustments to optimize its business structure [1]. - The company asserts that this transfer will not affect its normal production and operations [1]. - The financial status and operating results of the company will not be significantly impacted by this share transfer [1].

华康股份（605077）(605077.SH)公告，公司拟将持有宁波中药988.09万股股份，通过新三板以协议转让 方式，转让给方明本人，转让总价为2489.98万元。转让完成后，公司将不再持有宁波中药任何股份。 ...

| 证券代码：605077 | 证券简称：华康股份 | 公告编号：2025-066 | | --- | --- | --- | | 债券代码：111018 | 债券简称：华康转债 | | 浙江华康药业股份有限公司 关于转让参股公司股份的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： 交易标的：浙江华康药业股份有限公司（以下简称"公司"或"华康股份"） 持有的参股公司宁波中药制药股份有限公司（以下简称"宁波中药"）9,880,880 股 股份 一、交易概况 1、基本情况 2022 年，浙江华康药业股份有限公司以 21,976,440 元人民币认购宁波中药制 药股份有限公司（以下简称"宁波中药"）定向发行股票 8,518,000 股，并与宁 波中药签署《股票认购合同》、与宁波中药控股股东及实际控制人方明先生签署 《股票认购合同之补充协议》。具体内容详见公司于 2022 年 1 月 8 日、2 月 8 日、 3 月 11 日、5 月 24 日在上海证券交易所网站（http://www.sse.com.cn ...

人民财讯8月7日电，华康股份（605077）8月7日晚间公告，公司与方明签订《股份转让合同》，拟将持 有的宁波中药988.09万股股份，通过全国中小企业股份转让系统平台(新三板)，以协议转让方式，转让 给方明本人，转让总价为2489.98万元。转让完成后，公司将不再持有宁波中药任何股份。 ...

格隆汇8月7日丨华康股份(605077.SH)公布，2025年8月7日，公司与方明先生签订《股份转让合同》， 拟将持有宁波中药988.09万股股份，通过全国中小企业股份转让系统平台（新三板），以协议转让方 式，转让给方明本人，转让总价为人民币2489.98万元。本次转让完成后，公司将不再持有宁波中药任 何股份。 ...

Group 1 - The latest stock price of Huakang Co., Ltd. is 18.05 yuan, up 0.39% from the previous trading day, with a trading volume of 24,473 hands and a transaction amount of 44 million yuan [1] - The company has a total market capitalization of 5.47 billion yuan and a price-to-earnings ratio of 16.87 times [1] - Huakang Co., Ltd. operates in the food and beverage sector, focusing on the research and production of functional sugar alcohols, starch sugars, and health food ingredients [1] Group 2 - On August 6, the company disclosed the institutional research records from July 1, with 10 institutions including Guosen Securities and Southern Fund participating, focusing on the development of the company's sugar alcohol business [1] - This marks the 95th institutional research activity for the company in the past year [1] - On August 6, the net outflow of main funds was 3.41 million yuan, with a cumulative net outflow of 10.03 million yuan over the past five trading days [1]

数据来源：天眼查APP 证券之星消息，根据天眼查APP数据整理，近日，浙江大树舟康食品科技有限公司成立，法定代表人为 王欣，注册资本1000万元，经营范围包含：一般项目：技术服务、技术开发、技术咨询、技术交流、技 术转让、技术推广；食品添加剂销售；信息咨询服务(不含许可类信息咨询服务)；包装服务；食品进出 口；低温仓储(不含危险化学品等需许可审批的项目)(除依法须经批准的项目外，凭营业执照依法自主开 展经营活动)。许可项目：食品生产；食品添加剂生产；食品销售；食品互联网销售；粮食加工食品生 产；保健食品生产(依法须经批准的项目，经相关部门批准后方可开展经营活动，具体经营项目以审批 结果为准)。天眼查APP股权穿透显示，该公司由华康股份、苏州市捷睿翔投资管理有限公司、山东大 树达孚特膳食品有限公司共同持股。 ...